1989
DOI: 10.1159/000234943
|View full text |Cite
|
Sign up to set email alerts
|

Characteristic Nucleolar-Reticular Immunofluorescence Staining Pattern on Touch Prints of Hamster Liver: A Marker for Scl-70 Antibody

Abstract: Sera from 48 patients with systemic sclerosis (SSc) and from 62 patients with other connective tissue diseases were studied for nuclear staining patterns by indirect immunofluorescence (IIF) using touch prints of hamster liver, HEp-2 and cryostat sections of monkey esophagus as substrates. Immunodiffusion studies performed in all cases disclosed Scl-70 antibody in 36 SSc patients. The IIF pattern of Scl-70 antibody is characterized by diffuse granular and nucleolar staining on HEp-2, a combined nucleolar and d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2001
2001
2008
2008

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…The antigen was termed Scl‐70 after the molecular weight of approximately 70 kDa of the protein detected in first experiments. During later experiments with inhibitors of proteolysis, additional protein antigens of 86, 89, 95 and 100–105 kDa were identified, which specifically reacted with the Scl‐70 antibody 72 …”
Section: Scl‐70mentioning
confidence: 99%
“…The antigen was termed Scl‐70 after the molecular weight of approximately 70 kDa of the protein detected in first experiments. During later experiments with inhibitors of proteolysis, additional protein antigens of 86, 89, 95 and 100–105 kDa were identified, which specifically reacted with the Scl‐70 antibody 72 …”
Section: Scl‐70mentioning
confidence: 99%
“…Using a recombinant peptide as antigen has allowed better standardization with consistent results between different laboratories [16]. Specificity of anti-Scl 70 antibody for diffuse scleroderma is near to 98-100% [17][18][19][20]. Anti-Scl 70 antibodies are seldom seen in healthy people or patients without scleroderma.…”
Section: Discussionmentioning
confidence: 99%